Osimertinib efficacious as maintenance therapy in patients with stage III NSCLC
Crossref DOI link: https://doi.org/10.1038/s41571-024-00915-w
Published Online: 2024-06-17
Published Print: 2024-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2024-06-17
Version of Record valid from 2024-06-17
Article History
First Online: 17 June 2024